Literature DB >> 23296623

Clinical use of the calcium-binding S100B protein.

Ramona Astrand1, Johan Undén, Bertil Romner.   

Abstract

S100B is a calcium-binding protein most abundant in neuronal tissue. It is expressed in glia cells and Schwann cells and exerts both intra- and extracellular effects. Depending on the concentration, secreted S100B exerts either trophic or toxic effects. Its functions have been extensively studied but are still not fully understood. It can be measured in cerebrospinal fluid and blood, and increased S100B level in blood can be seen after, e.g., traumatic brain injury, certain neurodegenerative disorders and malignant melanoma. This chapter provides a short background of protein S100B, commercially available methods of analysis, and its clinical use.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296623     DOI: 10.1007/978-1-62703-230-8_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Role of biomarkers in the diagnosis of mild traumatic brain injury.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Yvonne W Lui
Journal:  Radiology       Date:  2013-08       Impact factor: 11.105

2.  S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury.

Authors:  Valentina Di Pietro; Angela Maria Amorini; Giacomo Lazzarino; Kamal Makram Yakoub; Serafina D'Urso; Giuseppe Lazzarino; Antonio Belli
Journal:  Neurochem Res       Date:  2015-04-22       Impact factor: 3.996

3.  S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.

Authors:  Andreia Barateiro; Vera Afonso; Gisela Santos; João José Cerqueira; Dora Brites; Jack van Horssen; Adelaide Fernandes
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

4.  Response.

Authors:  Yvonne W Lui
Journal:  Radiology       Date:  2013-08       Impact factor: 11.105

5.  Serum S-100β and NSE levels after off-pump versus on-pump coronary artery bypass graft surgery.

Authors:  Lei Zheng; Qing-Ming Fan; Zhen-Yu Wei
Journal:  BMC Cardiovasc Disord       Date:  2015-07-16       Impact factor: 2.298

6.  EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.

Authors:  Thomas Durand; Sophie Jacob; Laura Lebouil; Hassen Douzane; Philippe Lestaevel; Amithys Rahimian; Dimitri Psimaras; Loïc Feuvret; Delphine Leclercq; Bruno Brochet; Radia Tamarat; Fabien Milliat; Marc Benderitter; Nicolas Vayatis; Georges Noël; Khê Hoang-Xuan; Jean-Yves Delattre; Damien Ricard; Marie-Odile Bernier
Journal:  BMC Neurol       Date:  2015-12-18       Impact factor: 2.474

7.  Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury.

Authors:  William Hedley Thompson; Eric Peter Thelin; Anders Lilja; Bo-Michael Bellander; Peter Fransson
Journal:  Neuroimage Clin       Date:  2016-05-09       Impact factor: 4.881

8.  Senkyunolide H Affects Cerebral Ischemic Injury through Regulation on Autophagy of Neuronal Cells via P13K/AKT/mTOR Signaling Pathway.

Authors:  Bei Zhao; Ke-Cheng Tang; Ying Zhao; Wang Zhao
Journal:  Dis Markers       Date:  2022-10-03       Impact factor: 3.464

Review 9.  A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.

Authors:  Eric Peter Thelin; David W Nelson; Bo-Michael Bellander
Journal:  Acta Neurochir (Wien)       Date:  2016-12-12       Impact factor: 2.216

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.